Financhill
Sell
45

AKTX Quote, Financials, Valuation and Earnings

Last price:
$1.33
Seasonality move :
34.94%
Day range:
$1.20 - $1.35
52-week range:
$0.85 - $4.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.00x
Volume:
24.4K
Avg. volume:
24.9K
1-year change:
-21.28%
Market cap:
$43.4M
Revenue:
--
EPS (TTM):
-$1.18

Earnings Data

Next earnings date for AKTX
Aug 19
2025
Most recent earnings per share
--
Missed by --
(May 15/2025)
Consensus Estimate
--
(May 15/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

AKTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/15/2025 Q1 -- -- -- -- --
12/31/2024 Q4 -- -- -$0.14 -- --
09/30/2024 Q3 -- -- -$0.24 -- --
08/19/2024 Q2 -- -- -$0.80 -- --
05/16/2024 Q1 -- -- -$0.83 -- --
12/31/2023 Q4 -- -- -$0.88 -- --
09/30/2023 Q3 -- -- -$0.57 -- --
09/27/2023 Q2 -- -- -$0.79 -$1.00 $0.21
05/16/2023 Q1 -- -- $0.26 -$1.20 $1.46
12/31/2022 Q4 -- -- -- -$1.40 --
09/30/2022 Q3 -- -- -- -$0.80 --
09/27/2022 Q2 -- -- -$1.91 -- --
03/31/2022 Q1 -- -- -$1.93 -- --
12/31/2021 Q4 -- -- -$2.49 -- --
12/03/2021 Q3 -- -- -$0.62 -- --
09/22/2021 Q2 -- -- -$2.26 -- --
06/29/2021 Q1 -- -- -$3.04 -- --
03/31/2021 Q4 -- -- -$13.84 -- --
12/11/2020 Q3 -- -- $0.54 -- --
09/01/2020 Q2 -- -- -$4.96 -- --
05/29/2020 Q1 -- -- -$2.98 -- --
03/16/2020 Q4 -- -- -$7.30 -- --
11/04/2019 Q3 -- -- -$2.60 -- --
08/29/2019 Q2 -- -- -$5.12 -- --
04/23/2019 Q1 -- -- -$3.22 -- --
12/31/2018 Q4 -- -- -$4.44 -- --
11/15/2018 Q3 -- -- -$4.70 -- --
06/30/2018 Q2 -- -- -$20.00 -- --
03/31/2018 Q1 -- -- -$1.75 -- --
03/21/2018 Q4 -- -- -$20.00 -- --
09/30/2017 Q3 -- -- -$20.00 -- --
06/30/2017 Q2 -- -- -$0.54 -- --
03/31/2017 Q1 -- -- -$20.00 -- --
12/31/2016 Q4 -- -- -$20.00 -- --
09/30/2016 Q3 -- -- -$0.71 -- --
06/30/2016 Q2 -- -- -$20.00 -- --
03/31/2016 Q1 -- -- -$5.07 -- --
12/31/2015 Q4 -- -- $40.00 -- --
09/30/2015 Q3 -- -- -$120.00 -- --
06/30/2015 Q2 -- -- -$4.00 -- --

Akari Therapeutics PLC Earnings Questions

  • How Much did Akari Therapeutics PLC Generate in Revenue Last Quarter?

    Akari Therapeutics PLC reported -- worth of top line sales in its most recent quarter.

  • Did Akari Therapeutics PLC Beat Earnings Last Quarter?

    Akari Therapeutics PLC announced earnings per share of -- which represents a miss of analyst forecast a -- per share.

  • Is Akari Therapeutics PLC Profitable?

    Akari Therapeutics PLC reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Akari Therapeutics PLC EPS Next Year?

    Akari Therapeutics PLC's earnings are forecast to decrease from -- per share to -- per share next year representing a decrease of -29.64%.

  • When is Akari Therapeutics PLC's Earnings Date?

    Akari Therapeutics PLC's next earnings date is August 19, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Where Will Dell Stock Be in 5 Years?
Where Will Dell Stock Be in 5 Years?

So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock